Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation

Overview

Journal Nutrients

Date 2015 Jun 30

PMID 26121531

Citations 86

Authors

Hajar Mazahery

Pamela R von Hurst

Affiliations

Soon will be listed here.

Abstract

Sun exposure is the main source of vitamin D. Due to many lifestyle risk factors vitamin D deficiency/insufficiency is becoming a worldwide health problem. Low 25(OH)D concentration is associated with adverse musculoskeletal and non-musculoskeletal health outcomes. Vitamin D supplementation is currently the best approach to treat deficiency and to maintain adequacy. In response to a given dose of vitamin D, the effect on 25(OH)D concentration differs between individuals, and it is imperative that factors affecting this response be identified. For this review, a comprehensive literature search was conducted to identify those factors and to explore their significance in relation to circulating 25(OH)D response to vitamin D supplementation. The effect of several demographic/biological factors such as baseline 25(OH)D, aging, body mass index(BMI)/body fat percentage, ethnicity, calcium intake, genetics, oestrogen use, dietary fat content and composition, and some diseases and medications has been addressed. Furthermore, strategies employed by researchers or health care providers (type, dose and duration of vitamin D supplementation) and environment (season) are other contributing factors. With the exception of baseline 25(OH)D, BMI/body fat percentage, dose and type of vitamin D, the relative importance of other factors and the mechanisms by which these factors may affect the response remains to be determined.

Citing Articles

Falls and physical function in older patients with Benign Paroxysmal Positional Vertigo (BPPV): findings from a placebo controlled, double blinded randomized control trial (RCT) investigating efficacy of vitamin D treatment in lowering the....

Huang X, Chua K, Moh S, Yuen H, Low D, Anaikatti P Aging Clin Exp Res. 2025; 37(1):43.

PMID: 39985692 PMC: 11846746. DOI: 10.1007/s40520-025-02938-4.

Vitamin D levels and bone mineral density: a prospective cross-sectional analysis of young orthopedic trauma patients at a rural United States trauma center.

Booth M, Sabacinski K, Watkins C, Butcho E, Kramer E, Meadows L J Trauma Inj. 2024; 37(4):276-280.

PMID: 39736503 PMC: 11703697. DOI: 10.20408/jti.2024.0038.

Vitamin, antioxidant and micronutrient supplementation and the risk of developing incident autoimmune diseases: a systematic review and meta-analysis.

Low C, Loke S, Chew N, Lee A, Tay S Front Immunol. 2024; 15:1453703.

PMID: 39717776 PMC: 11663920. DOI: 10.3389/fimmu.2024.1453703.

Correlation between 25-hydroxyvitamin D and severe headache or migraine: evidence from NHANES database.

Zhang X, Wu J, Wu T, Guo L, Zhang R, Jin X Food Nutr Res. 2024; 68.

PMID: 39691689 PMC: 11650721. DOI: 10.29219/fnr.v68.10338.

Integrating Endocrine, Genomic, and Extra-Skeletal Benefits of Vitamin D into National and Regional Clinical Guidelines.

Wimalawansa S, Weiss S, Hollis B Nutrients. 2024; 16(22).

PMID: 39599755 PMC: 11597479. DOI: 10.3390/nu16223969.

References

Holick M, Biancuzzo R, Chen T, Klein E, Young A, Bibuld D . Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2007; 93(3):677-81. PMC: 2266966. DOI: 10.1210/jc.2007-2308. View

Need A, Nordin B . Misconceptions - vitamin D insufficiency causes malabsorption of calcium. Bone. 2008; 42(6):1021-4. DOI: 10.1016/j.bone.2008.01.012. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Saadi H, Dawodu A, Afandi B, Zayed R, Benedict S, Nagelkerke N . Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women. Am J Clin Nutr. 2007; 85(6):1565-71. DOI: 10.1093/ajcn/85.6.1565. View

Binkley N, Gemar D, Engelke J, Gangnon R, Ramamurthy R, Krueger D . Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab. 2011; 96(4):981-8. PMC: 3417158. DOI: 10.1210/jc.2010-0015. View

Gilman J, Shanahan F, Cashman K . Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr. 2006; 60(7):889-96. DOI: 10.1038/sj.ejcn.1602395. View

Blum M, Dolnikowski G, Seyoum E, Harris S, Booth S, Peterson J . Vitamin D(3) in fat tissue. Endocrine. 2008; 33(1):90-4. PMC: 2839878. DOI: 10.1007/s12020-008-9051-4. View

Mihai R, Farndon J . Parathyroid disease and calcium metabolism. Br J Anaesth. 2000; 85(1):29-43. DOI: 10.1093/bja/85.1.29. View

Elnenaei M, Chandra R, Mangion T, Moniz C . Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation. Br J Nutr. 2010; 105(1):71-9. DOI: 10.1017/S0007114510003065. View

10.

Clements M, Davies M, Fraser D, LUMB G, Mawer E, Adams P . Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci (Lond). 1987; 73(6):659-64. DOI: 10.1042/cs0730659. View

11.

Nimitphong H, Saetung S, Chanprasertyotin S, Chailurkit L, Ongphiphadhanakul B . Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D₃ or D₂supplementation. Nutr J. 2013; 12:39. PMC: 3637219. DOI: 10.1186/1475-2891-12-39. View

12.

Deluca H . Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004; 80(6 Suppl):1689S-96S. DOI: 10.1093/ajcn/80.6.1689S. View

13.

Stephenson A, Brotherwood M, Robert R, Atenafu E, Corey M, Tullis E . Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr. 2007; 85(5):1307-11. DOI: 10.1093/ajcn/85.5.1307. View

14.

Armas L, Hollis B, Heaney R . Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004; 89(11):5387-91. DOI: 10.1210/jc.2004-0360. View

15.

Talwar S, Aloia J, Pollack S, Yeh J . Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr. 2007; 86(6):1657-62. PMC: 2581841. DOI: 10.1093/ajcn/86.5.1657. View

16.

Holmberg I, Berlin T, Ewerth S, Bjorkhem I . 25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3. Scand J Clin Lab Invest. 1986; 46(8):785-90. DOI: 10.3109/00365518609084051. View

17.

Mulligan G, Licata A . Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res. 2010; 25(4):928-30. DOI: 10.1002/jbmr.67. View

18.

Kroll M, Bi C, Garber C, Kaufman H, Liu D, Caston-Balderrama A . Temporal relationship between vitamin D status and parathyroid hormone in the United States. PLoS One. 2015; 10(3):e0118108. PMC: 4349787. DOI: 10.1371/journal.pone.0118108. View

19.

Cantorna M, Hayes C, DeLuca H . 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A. 1996; 93(15):7861-4. PMC: 38839. DOI: 10.1073/pnas.93.15.7861. View

20.

Mazahery H, Stonehouse W, von Hurst P . The effect of monthly 50,000 IU or 100,000 IU vitamin D supplements on vitamin D status in premenopausal Middle Eastern women living in Auckland. Eur J Clin Nutr. 2014; 69(3):367-72. DOI: 10.1038/ejcn.2014.264. View